The drug maker reported consolidated net profit from continuing operations of Rs 354.49 crore in Q2 FY25 as against net loss of Rs 180.3 crore in Q2 FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback